References

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

10.1073/pnas.0608582104 · 2007 · External reference

Engineering precision nanoparticles for drug delivery

10.1038/s41573-020-0090-8 · 2021 · External reference

Facing the truth about nanotechnology in drug delivery

10.1021/nn404501g · 2013 · External reference

Recent progress on nanoparticle-based drug delivery systems for cancer therapy

10.20892/j.issn.2095-3941.2017.0052 · 2017 · External reference

Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomes

10.1016/j.jconrel.2017.03.392 · 2017 · External reference

The evolution of the protein corona around nanoparticles: a test study

10.1021/nn202458g · 2011 · External reference

Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases

10.1016/j.jconrel.2016.05.044 · 2016 · External reference

Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo

10.1016/j.jconrel.2021.07.048 · 2021 · External reference

Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo

10.1016/j.jconrel.2019.01.005 · 2019 · External reference

Recombinant fusion of glucagon-like peptide-1 and an albumin binding domain provides glycemic control for a week in diabetic mice

2020 · External reference

Conjugate of doxorubicin to albumin-binding peptide outperforms aldoxorubicin

10.1002/smll.201804452 · 2019 · External reference

Protein formulations for emulsions and solid-in-oil dispersions

10.1016/j.tibtech.2016.03.001 · 2016 · External reference

Albumin-based nanoparticles as potential controlled release drug delivery systems

10.1016/j.jconrel.2011.07.031 · 2012 · External reference

Assembly of multifunction dyes and heat shock protein 90 inhibitor coupled to bovine serum albumin in nanoparticles for multimodal photodynamic/photothermal/chemo-therapy

10.1016/j.jcis.2021.01.052 · 2021 · External reference

Nanoparticle albumin - bound (NAB) technology is a promising method for anti-cancer drug delivery

10.2174/157489209789206869 · 2009 · External reference

Albumin-bound paclitaxel: a next-generation taxane

10.1517/14656566.7.8.1041 · 2006 · External reference

Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles

10.1016/j.jconrel.2008.05.010 · 2008 · External reference

Harnessing albumin as a carrier for cancer therapies

10.1016/j.addr.2018.07.011 · 2018 · External reference

The molecular basis for the prolonged blood circulation of lipidated incretin peptides: peptide oligomerization or binding to serum albumin?

10.1016/j.jconrel.2016.08.035 · 2016 · External reference

Investigations of albumin–insulin Detemir complexes using molecular dynamics simulations and free energy calculations

10.1021/acs.molpharmaceut.9b00839 · 2020 · External reference

An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications

10.1016/j.omtn.2017.10.004 · 2017 · External reference

Resveratrol, genistein, and curcumin bind bovine serum albumin

10.1021/jp9115996 · 2010 · External reference

6749868 - protein stabilized pharmacologically active agents, and methods for the use therof

1999 · External reference

Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs, Expert Opin

2020 · External reference

Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity

10.1016/j.ijpharm.2010.10.041 · 2011 · External reference

Structural and functional changes in ultrasonicated bovine serum albumin solutions

10.1016/j.ultsonch.2005.07.006 · 2007 · External reference

Nanocomplexes of curcumin and glycated bovine serum albumin: the formation mechanism and effect of glycation on their physicochemical properties

2022 · External reference

Structural studies of bovine, equine, and leporine serum albumin complexes with naproxen

10.1002/prot.24583 · 2014 · External reference

Multi-channel in situ dynamic light scattering instrumentation enhancing biological small-angle X-ray scattering experiments at the PETRA III beamline P12

10.1107/s1600577517017568 · 2018 · External reference

Structures of bovine, equine and leporine serum albumin

10.1107/s0907444912027047 · 2012 · External reference

Spicy SDS-PAGE gels: curcumin/turmeric as an environment-friendly protein stain

10.1007/978-1-61779-821-4_51 · 2012 · External reference

Spherical gold nanoparticles impede the function of bovine serum albumin in vitro: a new consideration for studies in nanotoxicology

10.4172/2324-8777.1000124 · 2013 · External reference

Application of native polyacrylamide gel electrophoresis for protein analysis: bovine serum albumin as a model protein

10.1016/j.ijbiomac.2018.12.090 · 2019 · External reference

Serum albumin

10.1016/s0065-3233(08)60065-0 · 1985 · External reference

Fluorescence behavior of tryptophan residues of bovine and human serum albumins in ionic surfactant solutions: a comparative study of the two and one tryptophan(s) of bovine and human albumins

10.1007/bf01887115 · 1996 · External reference

Interaction between a potent corticosteroid drug - dexamethasone with bovine serum albumin and human serum albumin: a fluorescence quenching and fourier transformation infrared spectroscopy study

10.1016/j.jphotobiol.2010.05.014 · 2010 · External reference

Binding of curcumin with bovine serum albumin in the presence of ι-carrageenan and implications on the stability and antioxidant activity of curcumin

10.1021/jf401827x · 2013 · External reference

Human and bovine serum albumin time-resolved fluorescence: tryptophan and tyrosine contributions, effect of DMSO and rotational diffusion

10.1016/j.molstruc.2020.128805 · 2020 · External reference

Protein fluorescence

1983 · External reference

Spectroscopic analysis on the binding interaction of biologically active pyrimidine derivative with bovine serum albumin

10.1016/j.jpha.2015.07.001 · 2016 · External reference

Exploring the behavior of bovine serum albumin in response to changes in the chemical composition of responsive polymers: experimental and simulation studies

10.3390/polym8060238 · 2016 · External reference

Interaction of bovine serum albumin with two alkylimidazolium-based ionic liquids investigated by microcalorimetry and circular dichroism

2011 · External reference

Conductance changes in bovine serum albumin caused by drug-binding triggered structural transitions

10.3390/ma12071022 · 2019 · External reference

Induced circular dichroism as a tool to investigate the binding of drugs to carrier proteins: classic approaches and new trends

10.1016/j.jpba.2015.02.024 · 2015 · External reference

Interaction of curcumin with human serum albumin—a spectroscopic study

10.1007/s11745-999-0453-x · 1999 · External reference

Unique, pH-dependent biphasic band shape of the visible circular dichroism of curcumin–serum albumin complex

10.1016/s0006-291x(03)00030-5 · 2003 · External reference

Molecular basis of the Cotton effects induced by the binding of curcumin to human serum albumin

10.1016/s0957-4166(03)00486-5 · 2003 · External reference

Probing protein binding sites by circular dichroism spectroscopy

10.2174/1570163043335135 · 2005 · External reference

Analysis of binding interaction of curcumin and diacetylcurcumin with human and bovine serum albumin using fluorescence and circular dichroism spectroscopy

10.1007/s10930-009-9184-1 · 2009 · External reference

Albumin in medicine: pathological and clinical applications

2016 · External reference